Bumper Offer - Urjas oil Just @ Rs. 1
Mecobion NP is an allopathic medicine The correct dosage of Mecobion NP depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Mecobion NP is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
Is the use of Mecobion NP safe for pregnant women?
Pregnant women may experience moderate side effects from Mecobion NP. It is best to stop taking Mecobion NP immediately and inform your doctor if you notice any discomfort.
Is the use of Mecobion NP safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Mecobion NP. It should only be taken after medical advice.
What is the effect of Mecobion NP on the Kidneys?
Very few cases of side effects of Mecobion NP on kidney have been reported.
What is the effect of Mecobion NP on the Liver?
There are no any side effects of Mecobion NP on the liver.
What is the effect of Mecobion NP on the Heart?
You can take Mecobion NP without any fear of damage to the heart.
Mecobion NP should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Mecobion NP unless your doctor advises you to do so -
Is this Mecobion NP habit forming or addictive?
Mecobion NP does not cause addiction.
Interaction between Food and Mecobion NP
It is safe to take Mecobion NP with food.
Interaction between Alcohol and Mecobion NP
Taking alcohol with Mecobion NP can be dangerous.
This medicine data has been created by -
References
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 924-925
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Pamelor® (nortriptyline hydrochloride)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Lyrica (pregabalin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1048-1049
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 420
